In this week’s roundup: digital health updates including a draft guidance on artificial intelligence devices in China and a new FDA-adjacent Collaborative Community; a new all-hands-on-deck plan for EU IVDR implementation and more EU regulatory news; an updated guidance on device advertising in Saudi Arabia; more from China, Australia, and the US.
Welcome to MyStrategist
Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
Trial MyStrategist.com and unlock 7-days of exclusive subscriber-only access to MedTech Strategist & Market PathwaysStart Trial
A pioneer in endovascular robotics, Stereotaxis hit a wall just over a decade ago and was near extinction soon after. Now, with a new CEO in place, is the company finally poised to realize the potential of its technology?
Don't Just Advertise... Strategize!
Advertise with MedTech Strategist and be seen by medtech's most influential executives.Learn More
Members of Congress press HHS to reverse Trump administration's laboratory developed test policy.